Uluslar Arası Yayınlar
-
21 October 2020100
Serum neopterin levels in patients with breast cancer.
Yildirim Y, Gunel N, Coskun U, Pasaoglu H, Aslan S, Cetin A. Serum neopterin levels in patients with breast cancer. Med…
Read More » -
21 October 2020101
Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging. Clin Nucl Med.
Berk V, Yildiz R, Akdemir UO, Akyurek N, Karabacak NI, Coskun U, Benekli M. Disseminated extranodal NK/T-cell lymphoma, nasal type,…
Read More » -
21 October 2020100
Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma.
Yamac D, Ayyildiz T, Coşkun U, Akyürek N, Dursun A, Seckin S, Koybasioglu F. Cyclooxygenase-2 expression and its association with…
Read More » -
21 October 202088
Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimens.
Coskun U, Kaya AO, Buyukberber S, Benekli M, Uner A, Dikilitas M, Ozturk B, Yildiz R, Ozkan S, Yaman E, Yamac…
Read More » -
21 October 20203
Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatment.
Yaman E, Buyukberber S, Uner A, Coskun U, Akmansu M, Benekli M, Yamac D, Ozturk B, Kaya AO, Yildiz R, Ozkan…
Read More » -
21 October 202092
Prognostic factors for overall survival in patients with metastatic colorectal carcinoma treated with vascular endothelial growth factor-targeting agents.
Cetin B, Kaplan MA, Berk V, Ozturk SC, Benekli M, Isıkdogan A, Ozkan M, Coskun U, Buyukberber S. Prognostic factors…
Read More » -
21 October 202098
Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer.
Yildiz R, Benekli M, Ozkan M, Alkis N, Berk V, Kaplan MA, Ciltas A, Karaca H, Durnali AG, Coskun U, Dikilitas…
Read More » -
21 October 2020110
Long term experience in high grade glial tumors with temozolomide.
Demirci U, Buyukberber S, Coskun U, Akmansu M, Yaman E, Baykara M, Yamac D, Uner A, Benekli M. Long term experience…
Read More » -
21 October 2020147
Prognostic importance of markers for inflammation, angiogenesis and apoptosis in high grade glial tumors during temozolomide and radiotherapy.
Demirci U, Yaman M, Buyukberber S, Coskun U, Baykara M, Uslu K, Ozet A, Benekli M, Bagriacik EU. Prognostic importance of…
Read More » -
21 October 2020137
Trabectedin in advanced soft tissue sarcoma: case series.
Demirci U, Buyukberber S, Yetisyigit T, Dizdar O, Benekli M, Alkis N, Coskun U; Anatolian Society of Medical Oncology (ASMO).…
Read More »
